Cited by 423Liver physiology and pathologyLiver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Ductular reaction in liver diseases: pathological mechanisms and translational significances

Open access
Sato, Keisaku, Marzioni, Marco, Meng, Fanyin, Francis, Heather, Glaser, Shannon, Alpini, Gianfranco·2019·Hepatology

Abstract

Ductular reaction (DR) is characterized by the proliferation of reactive bile ducts induced by liver injuries. DR is pathologically recognized as bile duct hyperplasia and is commonly observed in biliary disorders. It can also be identified in various liver disorders including nonalcoholic fatty liver disease. DR is associated with liver fibrosis and damage, and the extent of DR parallels to patient mortality. DR raises scientific interests because it is associated with transdifferentiation of liver cells and may play an important role in hepatic regeneration. The origin of active cells during DR can be cholangiocytes, hepatocytes, or hepatic progenitor cells, and associated signaling pathways could differ depending on the specific liver injury or animal models used in the study. Although further studies are needed to elucidate detailed mechanisms and the functional roles in liver diseases, DR can be a therapeutic target to inhibit liver fibrosis and to promote liver regeneration. This review summarizes previous studies of DR identified in patients and animal models as well as currently understood mechanisms of DR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.30150

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CK7- and CK19-expressing ductular cells are significant promoters of fibrosis and interact with multiple cell types, including HSCs, portal fibroblasts and a wide range of immune cells.

    “Cytokeratin (CK)7- and CK19-expressing ductular cells are significant promoters of fibrosis and interact with multiple cell types, including HSCs, portal fibroblasts and a wide range of immune cells.49”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sato, K., Marzioni, M., Meng, F., Francis, H., Glaser, S., & Alpini, G.
Affiliations
  • Texas A&M Health Science Center (US)
  • Marche Polytechnic University (IT)
  • Baylor Scott & White Medical Center - Temple (US)
Corresponding author
Alpini, Gianfranco
Venue
Hepatology
Published
2018-12-27
Volume
69
Issue
1
Pages
420-430
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W2885037168
Cited by
423
References
73
Citations by year
2026: 43 · 2025: 44 · 2024: 64 · 2023: 70 · 2022: 89 · 2021: 47 · 2020: 38 · 2019: 24 · 2018: 4
FWCI
3.81
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
Funders
  • U.S. Department of Veterans Affairs (I01 BX000574, I01 BX003031, I01 BX001724, I01 BX002192)
  • National Institutes of Health
  • National Institute on Alcohol Abuse and Alcoholism (R21AA025997)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK115184, R01DK058411, R01DK108959, R01DK062975, R01DK107310, R01DK076898, R01DK110035)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
Keywords
ductular reaction, bile duct hyperplasia, liver fibrosis, liver regeneration, transdifferentiation, cholangiocytes, hepatocytes, hepatic progenitor cells, non-alcoholic fatty liver disease, biliary tract diseases, signaling pathways, therapeutic target
MeSH terms
Bile Ducts, Humans, Hyperplasia, Liver Diseases, Hepatocytes, Cell Proliferation, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review